Clinical Trial Update: An Observational Follow-up Study for Subjects Receiving Salvage Therapy After Previous Treatment in a Visilizumab Study for Intravenous Steroid-Refractory Ulcerative Colitis

View source ↗

Summary

An observational follow-up study is described for subjects receiving salvage therapy after prior treatment in a visilizumab study for intravenous steroid-refrac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Visilizumab (visilizumab)

Snippet

Sponsor: PDL BioPharma, Inc. | Conditions: Ulcerative Colitis | Status: TERMINATED